Literature DB >> 10900257

Bioactivation of selenocysteine Se-conjugates by a highly purified rat renal cysteine conjugate beta-lyase/glutamine transaminase K.

J N Commandeur1, I Andreadou, M Rooseboom, M Out, L J de Leur, E Groot, N P Vermeulen.   

Abstract

Selenocysteine Se-conjugates have recently been proposed as potential prodrugs to target pharmacologically active selenol compounds to the kidney. Although rat renal cytosol displayed a high activity of beta-elimination activity toward these substrates, the enzymes involved in this activation pathway as yet have not been identified. In the present study, the possible involvement of cysteine conjugate beta-lyase/glutamine transaminase K (beta-lyase/GTK) in cytosolic activity was investigated. To this end, the enzyme kinetics of 15 differentially substituted selenocysteine Se-conjugates and 11 cysteine S-conjugates was determined using highly purified rat renal beta-lyase/GTK. The results demonstrate that most selenocysteine Se-conjugates are beta-eliminated at a very high activity by purified beta-lyase/GTK, implicating an important role of this protein in the previously reported beta-elimination reactions in rat renal cytosol. As indicated by the rapid consumption of alpha-keto-gamma-methiolbutyric acid, purified beta-lyase/GTK also catalyzed transamination reactions, which appeared to even exceed that of beta-elimination. The corresponding sulfur analogs also showed significant transamination but were beta-eliminated at an extremely low rate. Comparison of the obtained enzyme kinetic data of purified beta-lyase/GTK with previously obtained data from rat renal cytosol showed a poor correlation. By determining the activity profiles of cytosolic fractions applied to anion exchange fast protein liquid chromatography and gel filtration chromatography, the involvement of multiple enzymes in the beta-elimination of selenocysteine Se-conjugates in rat renal cytosol was demonstrated. The identity and characteristics of these alternative selenocysteine conjugate beta-lyases, however, remain to be established.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10900257

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  13 in total

1.  Murine hepatoma (Hepa1c1c7) cells: a responsive in vitro system for chemoprotective enzyme induction by organoselenium compounds.

Authors:  Wael M El-Sayed; Tarek Aboul-Fadl; Jeanette C Roberts; John G Lamb; Michael R Franklin
Journal:  Toxicol In Vitro       Date:  2006-10-07       Impact factor: 3.500

2.  Activation energies of selenoxide elimination from Se-substituted selenocysteine.

Authors:  Craig A Bayse; Benjamin D Allison
Journal:  J Mol Model       Date:  2006-05-25       Impact factor: 1.810

3.  Metabolism of the cysteine S-conjugate of busulfan involves a beta-lyase reaction.

Authors:  Arthur J L Cooper; Islam R Younis; Zoya V Niatsetskaya; Boris F Krasnikov; John T Pinto; William P Petros; Patrick S Callery
Journal:  Drug Metab Dispos       Date:  2008-05-12       Impact factor: 3.922

Review 4.  Chemopreventive mechanisms of α-keto acid metabolites of naturally occurring organoselenium compounds.

Authors:  John T Pinto; Jeong-In Lee; Raghu Sinha; Melanie E MacEwan; Arthur J L Cooper
Journal:  Amino Acids       Date:  2010-04-10       Impact factor: 3.520

5.  Kynurenine aminotransferase III and glutamine transaminase L are identical enzymes that have cysteine S-conjugate β-lyase activity and can transaminate L-selenomethionine.

Authors:  John T Pinto; Boris F Krasnikov; Steven Alcutt; Melanie E Jones; Thambi Dorai; Maria T Villar; Antonio Artigues; Jianyong Li; Arthur J L Cooper
Journal:  J Biol Chem       Date:  2014-09-17       Impact factor: 5.157

6.  Site-Specific Incorporation of Selenocysteine Using an Expanded Genetic Code and Palladium-Mediated Chemical Deprotection.

Authors:  Jun Liu; Feng Zheng; Rujin Cheng; Shanshan Li; Sharon Rozovsky; Qian Wang; Lei Wang
Journal:  J Am Chem Soc       Date:  2018-07-09       Impact factor: 15.419

Review 7.  Cysteine S-conjugate β-lyases: important roles in the metabolism of naturally occurring sulfur and selenium-containing compounds, xenobiotics and anticancer agents.

Authors:  Arthur J L Cooper; Boris F Krasnikov; Zoya V Niatsetskaya; John T Pinto; Patrick S Callery; Maria T Villar; Antonio Artigues; Sam A Bruschi
Journal:  Amino Acids       Date:  2010-03-22       Impact factor: 3.520

8.  New insights into the metabolism of organomercury compounds: mercury-containing cysteine S-conjugates are substrates of human glutamine transaminase K and potent inactivators of cystathionine γ-lyase.

Authors:  Christy C Bridges; Boris F Krasnikov; Lucy Joshee; John T Pinto; André Hallen; Jianyong Li; Rudolfs K Zalups; Arthur J L Cooper
Journal:  Arch Biochem Biophys       Date:  2011-11-10       Impact factor: 4.013

9.  Substrate specificity of human glutamine transaminase K as an aminotransferase and as a cysteine S-conjugate beta-lyase.

Authors:  Arthur J L Cooper; John T Pinto; Boris F Krasnikov; Zoya V Niatsetskaya; Qian Han; Jianyong Li; David Vauzour; Jeremy P E Spencer
Journal:  Arch Biochem Biophys       Date:  2008-02-29       Impact factor: 4.013

10.  Alpha-keto acid metabolites of naturally occurring organoselenium compounds as inhibitors of histone deacetylase in human prostate cancer cells.

Authors:  Jeong-In Lee; Hui Nian; Arthur J L Cooper; Raghu Sinha; Jenny Dai; William H Bisson; Roderick H Dashwood; John T Pinto
Journal:  Cancer Prev Res (Phila)       Date:  2009-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.